One of the most common forms of cancers is lung cancer. The survival of lung cancer largely depends on the type of cancer, stage of cancer, the overall diagnosis and the health…
Study Investigates on Rare Genetic Variants that Increase Lung Cancer Risk
In US, lung cancer is one of the leading causes of cancer deaths among both men and women. The risk of this disease lies mainly with lifestyle factors like smoking and environmental…
Detecting Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients
Non-small cell lung cancer is the most prevalent form of lung cancer and accounts for more than 80% of all lung cancer cases. Circulating tumor cells (CTCs) lead to metastases and often…
Fenugreek – An Impressive Herb to Keep Your Lungs Healthy
Fenugreek is a common ingredient used in many Indian dishes and is often taken as a supplement. This herb has long been used in alternative medicine. It comes with light green leaves…
FDA Approves Libtayo as Monotherapy for Advanced NSCLC
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United States. Also, approximately 84% of all…
Study Says Deep Learning May Help Choose Better Lung Cancer Treatments
According to a study published in the International Journal of Medical Informatics, a deep learning tool was able to accurately predict the survival expectancy in lung cancer patients. This potentially helps in…
Lung Cancer Myth Busting: Long Term Use of Face Mask Cause Lung Cancer
The health officials all around the world encourage people to wear masks to slow down the spread of COVID 19 but according to a Facebook post, it claims that masks can give…
NICE Recommends Keytruda Plus Chemo for NSCLC Treatment
National Institute for Health and Care Excellence (NICE) has recommended Keytruda, alongside a combination of pemetrexed and platinum chemotherapy for first-line treatment of non-small cell lung cancer (NSCLC). This combination is recommended…
Amgen Drug, Sotorasib, Shows Success in Phase II Trial against Non-Small Cell Lung Cancer
An Amgen Inc. lung cancer drug, sotorasib, targets an aggressive genetic mutation called KRAS. In the Phase II trial, this drug has shown to provide durable clinical benefit with pretreated non-small cell…
Study on New Combination of Immunotherapy Shows Promising Lung Cancer Treatment
In a recent study, researchers have established that a novel combination of two forms of immunotherapy can be highly effective in treatment of lung cancer. This new treatment uses one form of…
No Association between Autoimmune Disease and Lung Cancer Survival, Study Finds
The deadly disease of lung cancer takes about 1.76 million cancer deaths worldwide. The well-known risk factors behind lung cancer include tobacco intake, cigarette smoking, environmental exposure etc. A history of autoimmune…
Testing your Home for Radon May Help to Prevent Lung Cancer
Radon is the second leading cause behind lung cancer in the United States. Although lung cancer can be treated but survival rate is one of the lowest for those having cancer. Radon…